Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Zoetis (NY: ZTS )

165.02 +1.53 (+0.94%)
Official Closing Price Updated: 7:00 PM EST, Jan 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zoetis

< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
Zoetis Named a “100 Best Company” and a “Best Company for Dads” by Seramount
From Zoetis Inc.
Via Business Wire
Zoetis to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
From Zoetis Inc.
Via Business Wire
Jim Cramer Says He Is Not Recommending This Group Of Stocks: 'They Don't Make Anybody Any Money'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes Paramount Global (NASDAQ: PARA) as it is "ridiculously cheap." 
Via Benzinga
Zoetis Return On Capital Employed Insights
  
Via Benzinga
Zoetis's Clocks Mixed Q2 Earnings, Lowers FY22 Profit Outlook
Via Benzinga
Zoetis Trims Full-Year Outlook Following Mixed Second Quarter
The guidance cut follows Zoetis' narrow earnings miss, though sales topped forecasts. 
Via Investor's Business Daily
Zoetis: Q2 Earnings Insights
  Zoetis (NYSE:ZTS) reported its Q2 earnings results on Thursday, August 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
CNBC's Final Trades: Chevron, Home Depot, Citigroup And This Pet Health Care Company
On CNBC’s “Halftime Report Final Trades,” Sarat Sethi said he’s sticking with Chevron Corporation (NYSE: CVX). 
Via Benzinga
Disney Gets CNBC's Fast Money Call Of The Day With These Final Trades
CNBC’s "Fast Money: Halftime Report" delivers market-moving news to investors. 
Via Benzinga
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,800 Today
Zoetis (NYSE:ZTS) has outperformed the market over the past 5 years by 12.96% on an annualized basis producing an average annual return of 23.7%. Currently, Zoetis has a market capitalization of $81.79... 
Via Benzinga
Animal Spirits: Nasdaq Up 19% Off June Lows
MARKET UPDATE 
Via Benzinga
4 Analysts Have This to Say About Zoetis
Analysts have provided the following ratings for Zoetis (NYSE:ZTS) within the last quarter: 
Via Benzinga
Zoetis Announces Second Quarter 2022 Results
From Zoetis Inc.
Via Business Wire
Zoetis Appoints Vanessa Broadhurst to its Board of Directors
From Zoetis Inc.
Via Business Wire
Tesla to $1,175? Here Are 5 Other Price Target Changes for Thursday
Mizuho raised Tesla, Inc. (NASDAQ: TSLA) price target from $1,150 to $1,175. However, Mizuho analyst Vijay Rakesh maintained a Buy rating on the stock. Tesla shares rose 3.3% to $766.88 in pre-market... 
Via Benzinga
$1000 Invested In Zoetis 5 Years Ago Would Be Worth This Much Today
Zoetis (NYSE:ZTS) has outperformed the market over the past 5 years by 13.96% on an annualized basis producing an average annual return of 23.78%. Currently, Zoetis has a market capitalization of... 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 12, 2022
Upgrades 
Via Benzinga
CNBC's Final Trades: Meta Platforms, Zoetis And This Stock Ahead Of Earnings
On CNBC’s “Halftime Report Final Trades,” Shannon Saccocia of Boston Private said she’s going with Meta Platforms Inc (NASDAQ: META), formerly known as Facebook. 
Via Benzinga
Here's How Much You Would Have Made Owning Zoetis Stock In The Last 5 Years
Zoetis (NYSE:ZTS) has outperformed the market over the past 5 years by 13.08% on an annualized basis producing an average annual return of 22.15%. Currently, Zoetis has a market capitalization of... 
Via Benzinga
Zoetis to Host Webcast and Conference Call on Second Quarter 2022 Financial Results
From Zoetis Inc.
Via Business Wire
CNBC's Final Trades: ChargePoint Holdings, Energy Puts, And These Pharma And Health Care Stocks To Buy
On CNBC’s “Halftime Report Final Trades,” Brenda Vingiello of Sand Hill Global Advisors said Zoetis Inc (NYSE: ZTS) is a pharma company “without all the problems 
Via Benzinga
Hot Stocks: 10 Tickers Moved By Traders on 'Fast Money Halftime Report'
CNBC’s "Fast Money Halftime Report" delivers market-moving news to investors. The commentary delivered by hosts of the show often moves the stocks mentioned.... 
Via Benzinga
Zoetis Completes Acquisition of Basepaws, an Innovative Leader in Petcare Genetics, to Strengthen its Portfolio of Precision Animal Health Solutions
From Zoetis Inc.
Via Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Good morning, investor! We're back with a breakdown of the biggest pre-market stock movers for Tuesday to get the day started! 
Via InvestorPlace
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,500 Today
Zoetis (NYSE:ZTS) has outperformed the market over the past 5 years by 11.89% on an annualized basis producing an average annual return of 20.56%. Currently, Zoetis has a market capitalization of... 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
During Monday's trading, 1214 companies set new 52-week lows. 
Via Benzinga
Zoetis to Participate in the Goldman Sachs 43rd Annual Global Healthcare Conference
From Zoetis Inc.
Via Business Wire
Zoetis Releases 2021 Sustainability Update to Share Progress in Championing Healthier Communities, Animals and the Planet
From Zoetis Inc.
Via Business Wire
Zoetis Announces Agreement to Acquire Basepaws, an Innovative Leader in Petcare Genetics, to Strengthen its Portfolio of Precision Animal Health Solutions
From Zoetis Inc.
Via Business Wire
< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.